Nell’ambito del programma scientifico del Congresso si è tenuta una Sessione Poster giovedì 14 marzo dalle ore 10.45 alle ore 11.45.

Di seguito l’elenco degli abstract presentati:

1. CORRELATION BETWEEN SERUM LEVELS OF PARATHYROID HORMONE AND ECHOCARDIOGRAPHIC PARAMETERS IN TERMINAL CHRONIC KIDNEY DISEASE PATIENTS (link)
2. INDOLE-3 ACETIC ACID INCREASED RISK OF IMPAIRED COGNITIVE FUNCTION IN PATIENTS RECEIVING HEMODIALYSIS (link)
3. PTH AND FIBROBLAST GROWTH FACTOR 23 AS EARLY MARKERS OF MINERAL AND BONE DISORDERS IN CHRONIC KIDNEY DISEASE PATIENTS (link)
4. SEVERITY OF MITRAL ANNULAR CALCIFICATION IN HAEMODIALYSIS PATIENTS (link)
5. EARLY REPOLARIZATION ELECTROCARDIOGRAPHIC PATTERN IN END-STAGE RENAL DISEASE PATIENTS ON DIALYSIS (link)
6. EARLY REPOLARIZATION ELECTROCARDIOGRAPHIC PATTERN RELATED TO LEVELS OF SERUM AND URINE PROTEIN IN PREDIALYSIS PATIENTS (link)
7. RENAL AND CUTANEOUS ANCA VASCULITIS WITH MILD CARDIAC COMPLAINTS: BE AWARE TO COCAINE-LEVAMISOLE ABUSE EVEN THOUGH PATIENT DENIES (link)
8. PERITONEAL ULTRAFILTRATION IN THE TREATMENT OF REFRACTORY HEART FAILURE: EXPERIENCE OF A CENTER. (link)
9. Effect of Sodium Fe+++ EDTA (FERACHEL FORTE®) administration on Cardiovascular risk evaluation: esporation of the HRV in the frequency domine. (link)
10. Point-of-care ultrasound in Cardio-renal Syndrome type 1: a case report (link)
11. LOWER GLOMERULAR FILTRATION RATE AT 1 YEAR IN KIDNEY TRANSPLANT RECIPIENT AS A PREDICTOR OF LEFT DIASTOLIC DYSFUNCTION (link)
12. TUBEROUS SCLEROSIS COMPLEX (TSC): RENAL AND CARDIOLOGICAL MANIFESTATIONS REQUIRE MULTIDISCIPLINARY APPROACH AND CAN BE PART OF THE UNDERSTANDING OF OTHER PREVALENT CONDITIONS (link)
13. INDANA CARDIOVASCULAR (CV) SCORE MAY SELECT HIGH-RISK RENAL TRANSPLANT PATIENTS FOR MACE WHO SHOULD UNDERGO AN AGGRESSIVE CV EVALUATION AT THE 5TH YEAR POST-TRANSPLANTATION (link)
14. EFFECTIVE COMMUNICATION AS A TOOL IN REDUCING RENAL GRAFT LOSS: IMPORTANCE OF MULTI-PROFESSIONAL TEAM TO INCREASE ADHERENCE TO TREATMENT (link)
15. Tissue advanced glycation end products (AGE) accumulation in end stage renal disease: peritoneal patients versus hemodialysis patients (link)
16. LIPIDS CONTROL AND ARTERIAL STIFFNESS IN RENAL TRANSPLANT RECIPIENTS (link)
17. DE-RESUSCITATION RATE IN ACUTE KIDNEY INJURY IN CRITICALLY ILL PATIENTS: DO REMOVE MORE IS THE BEST CHOICE? (link)
18. Impact of the functional state of thyroid gland on the prevalence of cardiovascular risk factors in patients with chronic kidney disease (link)
19. NEUTROPHIL-TO-LYMPHOCYTE RATIO AND MIR-126-3P AS BIOMARKERS OF NOCTURNAL AND RESISTANT HYPERTENSION IN CKD PATIENTS. (link)
20. Antihypertensive treatment and blood pressure control according to different standards in patients with chronic kidney disease (link)
21. Pulmonary Hypertension in Hemodialysis patients and its association with Oxidative stress and Inflammation (link)
22. ACUTE CARDIO RENAL SYNDROME IN ACUTE CORONARY SYNDROME -INCIDENCE, RISK FACTORS, OUTCOME AND THE ROLE OF URINE NGAL AS ITS BIO-MARKER (link)
23. HYPOMAGNESEMIA AS IMPORTANT COMPONENT OF ATHEROSCLEROSIS PROGRESSION IN TYPE 2 DIABETIC PATIENTS WITH END-STAGE RENAL DISEASE (link)
24. PREVALENCE OF ACUTE KIDNEY INJURY AFTER SURGICAL TREATMENT OF PRIMARY HYPERPARATHYROIDISM. (link)
25. RENAL REPLACEMENT THERAPY IN ACUTE KIDNEY INJURY (AKI); PROFILE AND MAIN OUTCOMES IN PATIENTS DIALYSED IN THE ICU UNIT OF A BRAZILIAN GENERAL HOSPITAL (link)
26. IMPLANTS OF LONG-TERM HEMODIALYSIS CATHETERS (PERMCATHS): EXPERIENCE IN A BRAZILIAN PRIVATE HOSPITAL (link)
27. ADOLESCENT IN ICU WITH CONVULSIONS, CEREBRAL EDEMA, AND ALKALOSIS: USE OF HEMODIAFILTRATION IN THE MANAGEMENT OF LEUCINOSIS (link)
28. SYSTEMIC TALCOSIS SECONDARY TO INTRAVENOUS ABUSE OF ORAL MORPHINE TABLETS (link)
29. PROFILE OF HOSPITAL ADMISSIONS OF CHRONIC RENAL PATIENTS IN HEMODIALYSIS DUE TO VASCULAR ACCESS FAILURE: A SINGLE CENTER STUDY (link)
30. Doxorubicin-induced hearth failure is dependent on both oxidative- and nitrosative stress. (link)
31. PULMONARY HYPERTENSION IN A DIALYSIS PATIENT: MODIFYING THE DIALYSIS SCHEDULE INSTEAD OF USING DRUGS (link)
32. L-ARGININI HYDROCHLORIDUM IN THE PERIOPERATIVE PERIOD IN PATIENTS WITH CHRONIC KIDNEY DESEASE AND COMORBIDITY (CORONARY ARTERY DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE) (link)
33. PALPABLE PURPURA, GET YOUR MIND OUT OF VASCULITIS: (link)
34. HYDROXYCHLOROQUINE CARDIOTOXICITY IN PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS ON HEMODIALYSIS. (link)
35. ICODEXTRIN-BASED PERITONEAL DIALYSIS AS THERAPEUTIC APPROACH IN CONGESTIVE HEART FAILURE RESISTANT TO PHARMACOLOGICAL TREATMENT (link)
36. PROTEIN-ENERGY WASTING AND FRAILTY IN ELDERLY DIALYSIS PATIENTS (link)
37. RELATIONSHIP BETWEEN RENAL FUNCTION AND AGE IN PATIENTS WITH CHRONIC HEART FAILURE AND PRESERVED EJECTION FRACTION (link)
38. RELATIONSHIP BETWEEN THE PRESENCE OF ATRIAL FIBRILLATION AND CHRONIC KIDNEY DISEASE IN PATIENTS WITH CORONARY HEART DISEASE (link)
39. CARDIORENAL AND METABOLIC SYNDROME IN RENAL PATIENTS (link)
40. IMPACT OF THE HEMODIALISIS AND HEART FAILURE ON RESPIRATORY FUNCTION IN PATIENTS WITH END-STAGE RENAL DISEASE (link)
41. DIAGNOSTIC VALUE OF SURFACTANT PROTEIN D IN HYPERTENSIVE PATIENTS WITH COMMUNITY ACQUIRED PNEUMONIA AND CHRONIC KIDNEY DISEASE (link)
42. HYPERTENSION IN ADPKD PATIENTS (link)